Yondelis 1Mg Trabectedin Injection
Yondelis 1Mg Trabectedin Injection

Yondelis 1Mg Trabectedin Injection

Price 98500 INR/ Vial

MOQ : 1 Vial

Yondelis 1Mg Trabectedin Injection Specification

  • Dosage Form
  • Lyophilized Powder
  • Salt Composition
  • Trabectedin 1 mg
  • Indication
  • Soft Tissue Sarcoma
  • Feature
  • Anticancer agent
  • Ingredients
  • Trabectedin
  • Application
  • Storage Instructions
  • Store below 25C
  • Shelf Life
  • 36 months
  • Packaging Type
  • Glass vial
  • Physical Color/Texture
  • White powder
  • Vial Volume
  • 1 vial
  • Reconstitution
  • Required before use
  • Strength
  • 1 mg
  • Route of Administration
  • IV infusion
  • Preservation
  • Keep away from light
 

Yondelis 1Mg Trabectedin Injection Trade Information

  • Minimum Order Quantity
  • 1 Vial
  • Supply Ability
  • 100 Vials Per Month
  • Delivery Time
  • 7 Days
 
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti Cancer Medicines Category

Balversa Erdafitinib 4Mg Tablet

Balversa Erdafitinib 4Mg Tablet

Price 12500 INR / Bottle

Minimum Order Quantity : 1 Bottle

Dosage Form : Tablet

Salt Composition : Erdafitinib

Shelf Life : 24 months

Indication : Bladder Cancer, Lung Cancer

Xtane Exemestane 25 Mg Tablet

Xtane Exemestane 25 Mg Tablet

Price 950 INR / Bottle

Minimum Order Quantity : 10 Bottles

Dosage Form : Tablet

Salt Composition : Exemestane

Shelf Life : 36 months

Indication : Breast Cancer

Soliris Eculizumab 300Mg

Soliris Eculizumab 300Mg

Price 95000 INR / Vial

Minimum Order Quantity : 1 Vial

Dosage Form : Injection

Salt Composition : Eculizumab

Shelf Life : 36 months

Indication : Paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome

Kalydeco Ivacaftor 150Mg

Kalydeco Ivacaftor 150Mg

Price 200000 INR / Bottle

Minimum Order Quantity : 1 Bottle

Dosage Form : Tablet

Salt Composition : Ivacaftor 150mg

Shelf Life : 24 months

Indication : Cystic Fibrosis in patients with specific gating (Class III) mutations in the CFTR gene



arrow